###begin article-title 0
###xml 95 99 <span type="species:ncbi:10090">Mice</span>
Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: AO MS HH. Performed the experiments: AO YO KK NS SM KK DN KY KF. Contributed reagents/materials/analysis tools: YF SH. Wrote the paper: AO.
###end p 1
###begin p 2
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
Recently, neurotrophic factors and cytokines have been shown to be associated in psychiatric disorders, such as schizophrenia, bipolar disorder, and depression. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the EGF family, serves as a neurotrophic molecular and plays a significant role in the brain. We generated mice in which HB-EGF activity is disrupted specifically in the ventral forebrain. These knockout mice showed (a) behavioral abnormalities similar to those described in psychiatric disorders, which were ameliorated by typical or atypical antipsychotics, (b) altered dopamine and serotonin levels in the brain, (c) decreases in spine density in neurons of the prefrontal cortex, (d) reductions in the protein levels of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor and post-synaptic protein-95 (PSD-95), (e) decreases in the EGF receptor, and in the calcium/calmodulin-dependent protein kinase II (CaMK II) signal cascade. These results suggest the alterations affecting HB-EGF signaling could comprise a contributing factor in psychiatric disorder.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 217 220 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Higashiyama1">[1]</xref>
###xml 222 225 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Watanabe1">[2]</xref>
###xml 227 230 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Barnard1">[3]</xref>
###xml 300 303 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Higashiyama1">[1]</xref>
###xml 311 314 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Elenius1">[4]</xref>
###xml 352 355 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Raab1">[5]</xref>
###xml 401 404 397 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Nishi1">[6]</xref>
###xml 585 588 581 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Ferrari1">[7]</xref>
###xml 590 593 586 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Ishiyama1">[8]</xref>
###xml 595 598 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Morrison1">[9]</xref>
###xml 658 662 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Mishima1">[10]</xref>
###xml 664 668 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hayase1">[11]</xref>
###xml 748 752 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Nakagawa1">[12]</xref>
###xml 754 758 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Kornblum1">[13]</xref>
###xml 760 764 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Farkas1">[14]</xref>
###xml 975 979 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Kornblum1">[13]</xref>
###xml 981 985 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Jin1">[15]</xref>
###xml 1148 1152 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Farkas1">[14]</xref>
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the EGF family of growth factors that includes EGF, transforming growth factor (TGF)-alpha, amphiregulin, betacelulin, and neuregulin [1], [2], [3]. HB-EGF binds to and activates the EGF receptor (EGF receptor/ErbB1) [1], ErbB4 [4], heparan sulfate proteoglycan (HSPG) [5], and N-arginine of dibasic convertase (NRDc) [6]. In the brain, EGF family members act as neurotrophic molecules, serving to enhance stem cell proliferation and neural differentiation, and they also influence synaptic plasticity [7], [8], [9]. HB-EGF is highly enriched in the neocortex and cerebellum [10], [11] and has been implicated in neuronal survival and glial/stem cell proliferation [12], [13], [14]. Recent studies indicate that this growth factor contributes to neurogenesis in the subventricular zone and adult hippocampus, thus maintaining multipotent neural progenitor cells expressing the ErbB1 receptor [13], [15]. HB-EGF also promotes the survival of dopaminergic neurons, an action mediated by mitogen-activated protein kinase (MAPK) as well as by the Akt signaling pathway [14]. For these reasons, HB-EGF may be an important contributor to neural development.
###end p 4
###begin p 5
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Rapoport1">[16]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Nasrallah1">[17]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Cicchetti1">[18]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Takahashi1">[19]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Futamura1">[20]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Futamura1">[20]</xref>
###xml 1115 1119 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hayase1">[11]</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 481 488 <span type="species:ncbi:9606">patient</span>
###xml 704 712 <span type="species:ncbi:9606">patients</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
Abnormal development of the brain is implicated in the etiology and/or pathology of various psychiatric diseases, including schizophrenia [16], bipolar disorder [17], and depression [18], among others. Similarly, psychiatric patients can display abnormalities in the expression of cytokines and neurotrophic factors. For instance, the levels of brain-derived neurotrophic factor (BDNF) expression are specifically elevated in the hippocampus and cingulated cortex of schizophrenic patient, while conversely, its receptor, trkB protein, is reduced in the prefrontal cortex and hippocampus of them [19]. EGF protein levels have been found to be lower in the prefrontal cortex and striatum of schizophrenic patients [20]. Serum EGF levels were also lower in these patients, whereas EGF receptor expression in the prefrontal cortex was elevated [20]. All of these findings indicate that the EGF signal cascade may contribute to the pathology of a number of psychiatric diseases. On the other hand, since peptides other than authentic EGF (e.g., TGF-alpha and HB-EGF) are expressed at much higher levels than EGF itself [11], it is possible that HB-EGF serves as a major physiologic ligand for the EGF receptor within the central nervous system.
###end p 5
###begin p 6
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
At the present time, little is known about the relationship between HB-EGF and psychiatric disorders. In the current study, therefore, we have generated HB-EGF conditional knockout (KO) mice that exhibit disruption of HB-EGF activity specifically in the ventral forebrain. We have compared the neurobehavioral and molecular biological characteristics of these mice with those of control mice and have demonstrated that the HB-EGF KO mice exhibit behavioral and biological abnormalities similar to those described in various psychiatric disorders. These results strongly suggest that alterations in HB-EGF signaling contribute to the pathogenesis of mental illness.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Generation of HB-EGF KO mice
###end title 8
###begin p 9
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Iwamoto1">[21]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Furuta1">[22]</xref>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1a</xref>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1b</xref>
###xml 820 826 820 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 936 950 936 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1d, and f</xref>
###xml 1000 1006 1000 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 1151 1158 1151 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1d</xref>
###xml 1205 1211 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 1279 1286 1279 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1d</xref>
###xml 1438 1445 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1g</xref>
###xml 1544 1552 1544 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007461.s002">Table S1</xref>
###xml 1730 1737 1730 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1d</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1273 1277 <span type="species:ncbi:10090">mice</span>
###xml 1420 1424 <span type="species:ncbi:10090">mice</span>
###xml 1694 1698 <span type="species:ncbi:10090">mice</span>
###xml 1820 1824 <span type="species:ncbi:10090">mice</span>
###xml 1847 1851 <span type="species:ncbi:10090">mice</span>
Since a homozygous null mutation of the Hb-egf gene causes lethality [21], in order to investigate the role of HB-EGF in the (adult/postnatal) brain, we generated ventral forebrain specific HB-EGF KO mice using a Cre-lox-mediated conditional gene KO approach with Six3 promoter [22]. This strategy for generating the HB-EGF KO mice, hereafter referred to as Cre (+/-) HB (lox/lox), is shown in Fig. 1a. The resulting Cre (+/-) HB (lox/lox) and control HB (lox/lox) mice were identified by polymerase chain reaction (PCR) analysis (Fig. 1b). HB (lox/lox) mice showed the same expression patterns for HB-EGF mRNA and protein in various regions of the brain (hippocampus, prefrontal cortex, cerebellum, and striatum) when compared with wild-type C57BL/6J mice (data not shown). Additionally, we confirmed the disruption of Hb-egf gene by lacZ staining. LacZ positive cells were founded in the prefrontal cortex and hippocampus in KO mice (Fig. 1d, and f). For a further examination of the expression of Hb-egf mRNA and its protein in HB-EGF KO and control mice, we performed in situ hybridization analysis and immunohistrochemical analysis respectively (Fig. 1d). In the prefrontal cortex, the expression of Hb-egf mRNA and protein were found to be considerably reduced in KO mice (Fig. 1d). Similarly, HB-EGF protein was undetectable beyond the background level in the cell layer of CA1, CA3, and dentate gyrus (DG) of KO mice hippocampus (Fig. 1g). However, we could detect no significant differences in the weights of individual brain regions (Table S1), and cresyl violet staining of adult brain sections showed no difference in the lamination or structure of cortical cells between HB-EGF KO mice and their control littermates (Fig. 1d). There were no significant differences in the body weight of adult KO or control mice. Mean body weights of mice used for each experiment are as follows: Locomotor activity and social interaction [Control; 27.0+/-0.51 g (mean+/-S.E.M., n = 25), KO; 26.6+/-0.52 g (n = 22)], PPI [Control; 25.5+/-0.33 g (n = 53), KO; 24.9+/-0.38 g (n = 65)], Monoamine analysis [Control; 25.2+/-0.69 g (n = 11), KO; 25.8+/-0.73 g (n = 11)], Y-maze, Novel object recognition test, and Western blotting [Control; 22.0+/-0.63 g (n = 6), KO; 22.0+/-0.73 g (n = 6)], and Morphological analysis [Control; 22.4+/-0.59 g (n = 5), KO; 21.6+/-0.74 g (n = 5)].
###end p 9
###begin title 10
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Generation of HB-EGF KO mice.
###end title 10
###begin p 11
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 458 464 458 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 1052 1058 1048 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 29 34 <span type="species:ncbi:10090">Mouse</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
###xml 1408 1412 <span type="species:ncbi:10090">mice</span>
###xml 1554 1558 <span type="species:ncbi:10090">mice</span>
(a) Gene-targeting strategy. Mouse Hb-egf cDNA containing the polyadenylation (pA) sequence flanked by loxP sequences was fused with the first exon of the mouse Hb-egf gene. The lacZ gene was inserted downstream of the Hb-egf cDNA. The targeting vector also contains the neomycin-resistance gene (neo), driven by the phosphoglycerate kinase (PGK) promoter and the diphtheria toxinA-fragment (DT-A) gene. Cre-mediated recombination results in the deletion of Hb-egf cDNA and in the expression of the lacZ gene. Exon sequences are indicated as black boxes. E, EcoR1; H, hind1; K, Kpnl; S, Sacll; V, EcoRV; X, Xhol. (b) Genotype of ventral forebrain-specific HB-EGF KO mice. Ventral forebrain-specific HB-EGF-deficient mice were confirmed by PCR as lox homozygous and Cre-recombinase positive. (c) Coronal section through the cortex region; square indicates area shown in the photomicrographs. (d) Histological analysis of cortex from controls (upper) and HB-EGF KO (lower) adult mice. LacZ staining, scale bar = 50 microm. In situ hybridization using an Hb-egf probe, scale bar = 100 microm. Immunohistochemical staining with anti-HB-EGF antibody, scale bar = 20 microm. Cresyl violet staining, scale bar = 500 microm. (e) Coronal section through the hippocampus; square indicates area shown in the photomicrographs (CA1, CA3, and DG). (f) LacZ staining of whole and individual hippocampal region in HB-EGF KO mice, scale bar = 500 microm. (g) Immunohistochemical analysis of individual hippocampal region from controls (upper) and HB-EGF KO (lower) adult mice, scale bar = 20 microm.
###end p 11
###begin title 12
###xml 10 14 <span type="species:ncbi:10090">mice</span>
HB-EGF KO mice exhibited abnormal psychomotor behaviors
###end title 12
###begin p 13
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2a</xref>
###xml 578 591 578 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2a and b</xref>
###xml 1411 1419 1411 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007461.s003">Table S2</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
###xml 1294 1298 <span type="species:ncbi:10090">mice</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
To investigate the involvement of HB-EGF in psychomotor behaviors, we performed several types of neurobehavioral tests. First, we studied the behavior of HB-EGF KO and control mice in their cages to measure locomotor activity. HB-EGF KO and control mice displayed a normal circadian rhythm (i.e., their activity was reduced during the light phase [8 A.M. to 8 P.M.] and then increased markedly at the beginning of the dark phase) (Fig. 2a). However, HB-EGF KO mice were more active than control mice over the 24-hr period (both dark and light phases) (P<0.05 vs. control mice) (Fig. 2a and b). During the first 0-3 hr of the test, HB-EGF KO mice were also more active than control mice, indicating that HB-EGF KO mice are also hyperactive in a novel environment. To test the involvement of dopaminergic and serotonergic neuronal systems in the increased locomotor activity, we examined the effects of a potent dopamine (DA) receptor antagonist, haloperidol, and a DA/serotonin (5-HT) receptor antagonist, risperidone and clozapine, in HB-EGF KO mice. Haloperidol (0.1 mg/kg, i.p.) ameliorated the hyperlocomotion of HB-EGF KO mice both in dark and light phases (P<0.05 vs. vehicle-treated HB-EGF KO mice in each phases). On the other hand, clozapine reduced the locomotor activity of HB-EGF KO mice only in light phase. Furthermore these drugs did not attenuate locomotor activity in control mice at each dose (Table S2).
###end p 13
###begin title 14
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Behavioral analysis of HB-EGF KO mice and control mice.
###end title 14
###begin p 15
###xml 35 39 <span type="species:ncbi:10090">Mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
###xml 1407 1412 <span type="species:ncbi:10090">mouse</span>
###xml 1785 1789 <span type="species:ncbi:10090">mice</span>
###xml 1839 1843 <span type="species:ncbi:10090">mice</span>
(a and b) Locomotor activity test. Mice were placed into individual cages, and their locomotion was assessed every hour for 1 day. Controls (n = 8), KO mice with treatment of vehicle (n = 7), haloperidol (n = 8), and clozapine (n = 8). (a) Locomotor activity throughout the 24-hr period, and (b) locomotor activity analyzed separately during day and night periods. (c) PPI of the acoustic startle response in control (n = 24), KO mice with treatment of vehicle (n = 24), haloperidol (n = 15), risperidone (n = 14), and clozapine (n = 12). The PPI is expressed as a percentage of the startle response to a 120 dB pulse. (d) Social interaction test in a novel environment in controls (n = 8) and KO mice with treatment of vehicle (n = 7), haloperidol (n = 9), and clozapine (n = 9). Two genetically identical mice that had been housed separately were placed in the same cage. Their social interaction was then monitored for 10 min. Values are means+/-SEM. (e and f) Novel-object recognition task. (e) In the training trial (5 min), two circles were placed in symmetrical left and right positions. (f) In the test trial 1 hr later (5 min), one circle (left) and one triangle (right) were placed in the same positions. The amount of time the control (n = 6) and KO (n = 6) mice spent exploring each object during training trial and test trial was recorded. * p<0.05 vs. left object. (g and h) Y-maze task. Each mouse was placed at the end of one fixed arm of the maze and allowed to move freely through the maze for 8 min. The sequence of arm entries was recorded manually. (g) Total number of arms entered during the session. (h) % of alternation was calculated as (actual alternations/maximum alternations) x100. Control (n = 6), KO (n = 6). Values are means+/-SEM. * p<0.05 vs. control mice. #p<0.05, ##p<0.01 vs. vehicle-treated HB-EGF KO mice.
###end p 15
###begin p 16
###xml 790 797 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2c</xref>
###xml 1092 1100 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007461.s003">Table S2</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 1073 1077 <span type="species:ncbi:10090">mice</span>
To investigate the possible role of HB-EGF in sensorimotor gating, prepulse inhibition (PPI) was measured in HB-EGF KO and control mice. Sensorimotor gating is the neural process in which allow attention to be focused on one stimulus. Sensorimotor gating can be assessed as PPI of startle, which is the modulation of the startle response, following a weak prepulse. In the pulse-only trials, startle amplitude did not differ significantly between HB-EGF KO and control mice, [Control; 263.7+/-33.56 (mean+/-S.E.M, n = 25), KO-vehicle; 205.8+/-35.25 (n = 24), KO-haloperidol; 230.2+/-60.6 (n = 15), KO-risperidone; 212.5+/-43.78 (n = 14), and KO-clozapine; 225.2+/-35.03 (n = 12)]. HB-EGF KO mice showed diminished PPI at prepulse intensities of both 73 and 76 dB (P<0.05 vs. control mice) (Fig. 2c). Moreover, PPI deficit observed in HB-EGF KO mice were significantly reversed by atypical antipsychotics, risperidone and clozapine (P<0.05 vs. vehicle-treated HB-EGF KO mice), but not by a typical neuroleptic haloperidol (P>0.05). These drugs did not affect PPI in control mice at each dose (Table S2).
###end p 16
###begin p 17
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2d</xref>
###xml 983 990 983 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2d</xref>
###xml 1733 1741 1713 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007461.s003">Table S2</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">Mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
###xml 1348 1352 <span type="species:ncbi:10090">mice</span>
###xml 1471 1475 <span type="species:ncbi:10090">mice</span>
###xml 1714 1718 <span type="species:ncbi:10090">mice</span>
To assess the social affiliative behavior of HB-EGF KO mice, we employed a social interaction paradigm. When introduced to another mouse, a normal mouse will typically investigate the new mouse by walking over and sniffing it. But animal models of psychiatric disorders tend to show decreases in such social-interaction behavior. During a 10 min social interaction test in a novel environment, the mean duration per contact was significantly less in HB-EGF KO mice than in control mice, indicating that HB-EGF KO mice spent significantly less time engaging in social contact (P<0.05 vs. control mice) (Fig. 2d). We could not detect any differences in olfactory sensation between either genotype (data not shown). Mice were pretreated with haloperidol or clozapine for 7 days and subjected to the social interaction test. Clozapine, but not haloperidol, significantly attenuated the decreased social interaction behavior of HB-EGF KO mice (P<0.05 vs. vehicle-treated HB-EGF KO mice) (Fig. 2d). During a 10 min social interaction test, not only the mean duration per contact but also the time of interaction were significantly less in HB-EGF KO mice than in control mice [Control; 41.7+/-3.37 sec (mean+/-S.E.M, n = 8), KO-vehicle; 27.1+/-5.13* sec (n = 7), KO-haloperidol; 21.0+/-2.68 (n = 9), KO-clozapine; 24.7+/-2.44 (n = 9), *p<0.05 vs. control mice]. On the other hand, no significant changes were observed in the number of interactions between HB-EGF KO and Control mice [Control; 20.4+/-1.31 counts (mean+/-S.E.M, n = 8), KO-vehicle; 18.4+/-2.72 counts (n = 7), KO-haloperidol; 14.7+/-1.86 (n = 9), KO-clozapine; 13.2+/-1.31 (n = 9)]. Furthermore these drugs did not affect the social interaction in control mice at each dose (Table S2).
###end p 17
###begin p 18
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2e</xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2f</xref>
###xml 669 676 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2f</xref>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
Using a novel-object recognition test, we next investigated the effect of deletion of the Hb-egf gene on learning and memory performance. The exploratory behavior of the HB-EGF KO mice and control mice did not differ during the training session (P>0.05 vs. control mice) (Fig. 2e). However, in the test trials conducted 1 hr after the training session, control mice spent significantly more time exploring a new object than a familiar object, exhibiting a clear preference for the novel object (P<0.05 vs. control mice) (Fig. 2f). In contrast, HB-EGF KO mice spent equal amounts of time investigating the novel object and the familiar object (P>0.05 vs. control mice) (Fig. 2f).
###end p 18
###begin p 19
###xml 416 423 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2g</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g002">Fig. 2h</xref>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
Next, to further assess the specificity of changes in working memory related to the loss of HB-EGF protein, we elected to test spontaneous alternation in the Y-maze, which is devoid of any procedural bias because it is based on the natural tendency of mice to explore a novel environment. There was no difference in the number of arm choices or in preference for a particular arm between HB-EGF KO and control mice (Fig. 2g). However, HB-EGF KO mice displayed a significant decrease in alternation compared to control mice (P<0.05 vs. control mice) (Fig. 2h).
###end p 19
###begin title 20
Changes in monoamine levels
###end title 20
###begin p 21
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hashimoto1">[23]</xref>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 558 565 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g003">Fig. 3a</xref>
###xml 717 730 717 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g003">Fig. 3b and c</xref>
###xml 929 936 929 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g003">Fig. 3d</xref>
###xml 1148 1157 1148 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007461.s001">Figure S1</xref>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
It is commonly believed that behavioral abnormalities are associated with alterations in monoaminergic transmission [23]. To investigate whether targeted disruption of the Hb-egf gene affected the function of monoaminergic neuronal systems, tissue levels of monoamines and their metabolites were assessed in various regions of the brain in HB-EGF KO and control mice. In the prefrontal cortex, DA, 5-HT, and its metabolite 5-hydroxyindole acetic acid (5-HIAA) levels were statistically lower in HB-EGF KO mice than in control mice (P<0.05 vs. control mice) (Fig. 3a). The 5-HT level in the thalamus and the DA levels in the cerebellum were also lower in HB-EGF KO mice than in control mice (P<0.05 vs. control mice) (Fig. 3b and c). In contrast, the striatal norepinephrine (NE), its metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG), and 5-HT levels were higher in HB-EGF KO mice than in control mice (P<0.05 vs. control mice) (Fig. 3d). On the other hand, no significant differences in monoamine metabolites in various regions of the brain (prefrontal cortex, thalamus, cerebellum, and striatum) were observed between HB-EGF KO and control mice (Figure S1).
###end p 21
###begin title 22
Tissue monoamine levels of individual brain regions.
###end title 22
###begin p 23
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
Levels of monoamine neurotransmitters and their major metabolites were assayed in the (a) prefrontal cortex, (b) thalamus, (c) cerebellum, and (d) striatum of controls (n = 11) and HB-EGF KO (n = 11) mice. Values are means+/-SEM. * p<0.05, ** p<0.01 vs. control mice. NE: Norepinephrine, MHPG: 3-methoxy 4-hydroxy phenethyleneglycol, DA: Dopamine, DOPAC: 3,4-dihydroxyphenilacetic acid, 3-MT: 3-methoxytyramine, HVA: homovanillic acid, 5-HT: Serotonin, 5-HIAA: 5-hydroxyindol acetic acid.
###end p 23
###begin title 24
Morphological changes in the prefrontal cortex
###end title 24
###begin p 25
###xml 206 215 206 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4a&#8211;c</xref>
###xml 467 480 467 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4a and e</xref>
###xml 664 681 660 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4b, c, and f</xref>
###xml 807 814 803 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4g</xref>
###xml 980 987 976 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4h</xref>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
To try to identify possible morphological correlates of the observed abnormalities of behavior and cognition, we analyzed the morphology of pyramidal neurons in cortical layer III in the prefrontal cortex. Fig. 4a-c shows the morphology of such neurons in control (left) and HB-EGF KO (right) mice. In these neurons, (I) there was no significant difference in the number of basal dendritic branch-points between controls and HB-EGF KO mice (P>0.05 vs. control mice) (Fig. 4a and e); (II) as regards spine density in primary apical dendrites, the number of spines per 10 microm of dendritic segment was lower in KO than in control mice (P<0.0001 vs. control mice) (Fig. 4b, c, and f); (III) there was no significant difference in dendrite length between adult controls and KO mice (P>0.05 vs. control mice) (Fig. 4g); and (IV) as regards the cumulative distribution of spine length, there was no significant difference between adult controls and KO mice (P>0.05 vs. control mice) (Fig. 4h).
###end p 25
###begin title 26
Morphological changes in the prefrontal cortex.
###end title 26
###begin p 27
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1279 1283 <span type="species:ncbi:10090">mice</span>
(a) Representative photomicrographs showing morphology of pyramidal neurons in cortical layer III of the prefrontal cortex from control (left) and KO (right) mice. Scale bar = 20 microm. (b) Representative photomicrographs of apical dendritic segments from control (left) and KO (right) mice. Scale bar = 8 microm. (c) High-magnification images of apical dendritic segments from adult control (left) and KO (right) mice. Scale bar = 2 microm. (d) Representative images of immunoblots showing NR1 and PSD-95 protein levels. (e) Quantification of the number of basal dendritic branch-points. (f) Spine density on primary apical dendrites of layer III pyramidal neurons of the prefrontal cortex from control (white bar) and KO (black bar) mice. (g) Quantification of spine length. Control (n = 700 spines) and KO (n = 592 spines) mice (n = 4 mice, 25 neurons each). (h) Cumulative distribution of spine length. Control (white circle) and KO (black circle) mice (n = 4 mice, 25 neurons each). (i, j, k, and l) Quantitative analysis of NR1, PSD-95, NR2A, and NR2B by densitometric scanning of immunoreactive bands. Control (n = 5), KO (n = 5). Data for control and KO mice are expressed as a percentage of the control value. Values are means+/-SEM. ** p<0.01, *** p<0.001 vs. control mice.
###end p 27
###begin p 28
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4d</xref>
###xml 394 411 394 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4d, i, and j</xref>
###xml 581 594 581 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g004">Fig. 4k and l</xref>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
Next, we assessed by western blotting the protein levels of NR1 and PSD-95 as the obligatory subunits of the NMDA receptor and its interacting molecule, which are thought to be involved in the pathophysiology of schizophrenia. Fig. 4d shows immunoreactive bands for NR1 and PSD-95. Both NR1 and PSD-95 were markedly reduced in the prefrontal cortex of HB-EGF KO mice (P<0.01 vs. control mice) (Fig. 4d, i, and j). In contrast, no significant differences were observed in the expression of NR2A and total NR2B proteins between controls and HB-EGF KO mice (P>0.05 vs. control mice) (Fig. 4k and l).
###end p 28
###begin title 29
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Dysfunction of CaMKII and its related signals in HB-EGF KO mice
###end title 29
###begin p 30
###xml 277 290 263 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g005">Fig. 5a and c</xref>
###xml 479 486 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g005">Fig. 5d</xref>
###xml 553 560 532 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g005">Fig. 5b</xref>
###xml 727 740 706 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g005">Fig. 5e and f</xref>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
By using western blotting, we next evaluated the protein levels of total CaMKII alpha and beta, phosphorylated CaMKII (p-CaMKII) alpha and beta, p21-activated kinase (p-PAK)1/3, and p-PAK2, which are serine-threonine kinases that regulate the synaptic architecture in neurons. Fig. 5a and c show immunoreactive bands for total CaMKII and p-CaMKII, respectively. P-CaMKII (alpha and beta) was markedly reduced in the prefrontal cortex of HB-EGF KO mice (P<0.01 vs. control mice) (Fig. 5d), despite the presence of a normal level of total CaMKII protein (Fig. 5b). Likewise, protein levels of p-PAK1/3 and p-PAK2 were significantly lower in the prefrontal cortex in HB-EGF KO mice than in control mice (P<0.01 vs. control mice) (Fig. 5e and f).
###end p 30
###begin title 31
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Activation of CaMKII and its related signals in HB-EGF KO and control mice.
###end title 31
###begin p 32
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
Representative images of immunoblotting showing total CaMKII (a), p-CaMKII (c), p-PAK1/3, and p-PAK2 (e). Quantitative analysis of total CaMKII (b), p-CaMKII (d), p-PAK1/3, and p-PAK2 (f) by densitometric scanning of immunoreactive bands. Data for control (n = 5) and KO (n = 5) mice are expressed as a percentage of the control value. Values are means+/-SEM. * p<0.05 vs. control mice.
###end p 32
###begin title 33
Expression of the EGF receptor and its signals
###end title 33
###begin p 34
###xml 375 388 375 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g006">Fig. 6a and b</xref>
###xml 572 579 572 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g006">Fig. 6c</xref>
###xml 828 835 828 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g006">Fig. 6d</xref>
###xml 1010 1023 1010 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g006">Fig. 6e and f</xref>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
###xml 1003 1007 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1556 1560 <span type="species:ncbi:10090">mice</span>
To investigate the mechanisms that might lead to the observed behavioral abnormalities and altered monoamine levels, we compared the expression of the EGF receptor and its signaling in HB-EGF KO and control mice. No significant differences in the expression of total EGF receptor or ErbB4 proteins were observed between controls and HB-EGF KO mice (P>0.05 vs. control mice) (Fig. 6a and b). Despite these equivalent levels of EGF receptor expression, p-EGF receptor protein was significantly decreased in the prefrontal cortex of HB-EGF KO mice (P<0.05 vs. control mice) (Fig. 6c). Moreover, the expression of phosphorylated extracellular signal-regulated kinase (p-ERK) protein was significantly decreased in the prefrontal cortex of HB-EGF KO mice (P<0.05 vs. control mice), despite comparable levels of total ERK expression (Fig. 6d). No significant differences in the expression of phosphorylated and total Akt or ErbB4 proteins were observed between controls and HB-EGF KO mice (P>0.05 vs. control mice) (Fig. 6e and f). On the other hand, we did not detect significant differences between controls and KO mice regarding the relative expression of other EGF family growth factors, such as EGF [Control; 100+/-4.58 (mean+/-S.E.M., n = 10), KO; 104+/-6.94 (n = 10)], TGF-alpha [Control; 100+/-11.8 (n = 10), KO; 104+/-9.36 (n = 10)], and betacelulin [Control; 100+/-6.59 (n = 10), KO; 99.6+/-6.48 (n = 10)], using real-time PCR. No Real-time PCR activity for epiregulin mRNA was observed under our experimental conditions in either HB-EGF KO or control mice.
###end p 34
###begin title 35
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Expression of EGF receptor and its signals in HB-EGF KO and control mice.
###end title 35
###begin p 36
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
Representative images of immunoblots showing EGF receptor and beta-actin (a), ErbB4 and beta-actin (b), p-EGF receptor and total EGF receptor (c), p-ERK, ERK, and beta-actin (d), p-Akt, Akt, and beta-actin (e), and p-ErbB4 and ErbB4 (f) in the prefrontal cortex (upper). Quantitative analysis of EGF receptor (a), ErbB4 (b), p-EGF receptor (c), p-ERK (d), p-Akt (e), and p-ErbB4 (f) by densitometric scanning of immunoreactive bands, with normalization to the signals for beta-actin (a and b), EGF receptor (c), ERK (d), Akt (e), or ErbB4 (f) (lower). Data for control (n = 5) and KO (n = 5) mice are expressed as a percentage of the control value. Values are means+/-SEM. * p<0.05 vs. control mice.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Oliver1">[24]</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
In this study, we generated conditional HB-EGF KO mice using a Cre/loxP system and were able to confirm the disruption of HB-EGF in the prefrontal cortex and hippocampus of KO mice. These results corresponded with a previous report which detected the Six3 expression in the ventral forebrain and basal ganglion [24]. Despite the decreased expression HB-EGF, the overall development of HB-EGF KO mice appeared to be normal and there were no significant differences in the body weight in the adult KO or control mice. We also detected no significant differences in the weights of individual brain regions, and adult brain sections showed no difference in the lamination or structure of cortical cells when investigated in either HB-EGF KO mice or their control littermates.
###end p 38
###begin p 39
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Harvey1">[25]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-WinogradGurvich1">[26]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Gainetdinov1">[27]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Yan1">[28]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Noda1">[29]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Linn1">[30]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-SamsDodd1">[31]</xref>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
To investigate the roles of HB-EGF in psychomotor behavior, we performed a comprehensive behavioral analysis of ventral forebrain-specific HB-EGF KO mice. Deficiencies in PPI and memory tasks are considered to be signs of cognitive dysfunction [25], whereas social withdrawal is one of the most disabling symptoms in psychiatric disorders such as depression and schizophrenia [26]. Hyperactivity is a characteristic of the rodent models of several psychiatric disorders, such as schizophrenia [27] and attention deficit hyperactivity disorder (ADHD) [28] and could correspond to psychomotor agitation observed in human patients with these disorders. The behavioral impairments observed in HB-EGF KO mice were similar to those observed in mice with treatment of NMDA receptor antagonists such as phencyclidine (PCP) [29], [30], [31]. Consistent with these reports, in the present studies, treatments with either a typical or an atypical antipsychotic drug ameliorated these behavioral impairments in KO mice. A typical antipsychotic (haloperidol) reduced the locomotor activity of KO mice, but not the social withdrawal or the deficit of PPI. In contrast, atypical antipsychotics (clozapine and risperidone) ameliorated the impairments of social interaction and PPI.
###end p 39
###begin p 40
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Sarter1">[32]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Tang1">[33]</xref>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
HB-EGF KO mice also displayed deficit of memory related behavior, as observed by the Y-maze test performance and novel-object recognition test. These deficits are considered to be signs of cognitive and working memory dysfunction, respectively [32], [33]. Taken together, the results from the present study indicate that HB-EGF KO mice present with a comprehensive spectrum of psychomotor and cognitive dysfunctions, all of which are characteristic of rodent models of psychiatric disorders, such as schizophrenia.
###end p 40
###begin p 41
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hashimoto1">[23]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Carlsson1">[34]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Moore1">[35]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Farkas1">[14]</xref>
###xml 592 598 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
In general, abnormal behaviors are accompanied by altered monoamine levels in animal models of psychiatric disorders [23]. Contrary to the classical DA hypothesis, which proposes that hyperactivity of DA transmission is responsible for schizophrenia [34], the DA level was statistically lower in the prefrontal cortex of the HB-EGF KO mice than in the control mice. However, a recent DA hypothesis of schizophrenia also indicates a decrease in DA level in the prefrontal cortex [35]. HB-EGF is known to promote the survival of midbrain dopaminergic neurons [14]; therefore, the absence of an Hb-egf gene might be expected to result in hypoplasia and hypofunction of dopaminergenic neurons. On the other hand, the upregulation of NE, 5-HT, and its metabolites observed in the striatum of the KO mice in the present study may compensate for the downregulation of the prefrontal monoamine levels.
###end p 41
###begin p 42
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Nabeshima1">[36]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Miyamoto1">[37]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Mouri1">[38]</xref>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
The presence of NMDA receptor hypofunction in psychiatric disorder has been inferred recently from a large number of clinical and preclinical observations [36]. Genetic experiments in animals suggest that the NR1 subunit, an essential part of the NMDA receptor, plays an important role in cognitive function [37], [38]. In the present study, NR1 protein was markedly reduced in the prefrontal cortex of HB-EGF KO mice. Malfunctioning NMDA receptor signaling in the prefrontal cortex of KO mice may lead to dysfunction in this brain region, perhaps resulting in the impairments of recognition and spatial working memory that were observed in this study.
###end p 42
###begin p 43
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Harris1">[39]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Yuste1">[40]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-PorteraCailliau1">[41]</xref>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Glantz1">[42]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hayashi1">[43]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Ultanir1">[44]</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Ehrlich1">[45]</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 1084 1088 <span type="species:ncbi:10090">mice</span>
The most significant finding made in the present study was that the HB-EGF KO mice had a significantly decreased spine density on the primary apical dendrites of the layer III pyramidal neurons of the prefrontal cortex (vs. control mice) of approximately 40%. Since the dendritic spine is the major site of excitatory synaptic transmission in the central nervous system, the size and density of these spines will clearly influence the operation of functional circuits [39], [40], [41]. In schizophrenic patients, spine density of these neurons is decreased compared with normal controls [42]. The KO mice also showed decreased expression of the NR1, PSD-95, p-CaMKII, and PAK families, and these signaling pathways are known to regulate synaptic structure and function in the developing cortex [43], [44], [45]. Thus, the morphological changes observed in dendritic spines may have been a result of the observed decreases in the expression of the NR1, PSD-95, p-CaMKII, and PAK families. These in turn may have led to the abnormalities in behavior and monoamine levels seen in the KO mice.
###end p 43
###begin p 44
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Futamura1">[20]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Futamura2">[46]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-GomezPinilla1">[47]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Adamson1">[48]</xref>
###xml 518 522 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Hayase1">[11]</xref>
###xml 907 913 903 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 956 962 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 1040 1044 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Mine1">[49]</xref>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
Additionally, current evidence indicates that cytokines and growth factors can strongly influence neural phenotypic differentiation and subsequent neural function. Some studies have indicated a potential link between impaired EGF signaling and the pathogenesis of schizophrenia [20], [46]. The EGF receptor is expressed ubiquitously in both the developing and the adult brain [47], [48]. However, since peptides other than authentic EGF (e.g., TGF-alpha and HB-EGF) are expressed at much higher levels than EGF itself [11], HB-EGF itself could be serving as a major physiologic ligand for EGF receptor within the central nervous system. In the present study, we detected a decrease in p-EGF receptor protein and subsequent activation of ERK signaling in the prefrontal cortex of HB-EGF KO mice (vs. control mice). Consistent with our results, a previous study (using the same line of mice with loxP-flanked Hb-egf cDNA) demonstrated that a mutation of the Hb-egf gene was associated with decreases in the activation of EGF receptor and ERK [49].
###end p 44
###begin p 45
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Satoh1">[50]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Pereira1">[51]</xref>
###xml 489 495 489 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
MAPKs, also known as ERKs, operate in a signaling cascade that regulates various cellular processes (such as proliferation, differentiation, and cell cycle progression). ERKs are recognized as being important signaling components in learning and memory and in regulating dendritic spine density [50]. Current evidence indicates that continued exposure to clozapine stimulates p-ERKs, mediated by the EGF receptor [51]. Down-regulation of EGF receptor signaling, induced by mutation of the Hb-egf gene, could affect synaptic plasticity by regulating NDMA relating proteins, and this would lead to the abnormal behaviors observed in HB-EGF KO mice.
###end p 45
###begin p 46
###xml 61 65 <span type="species:ncbi:10090">mice</span>
In conclusion, the current study demonstrates that HB-EGF KO mice exhibited the behavioral abnormalities reflected in a comprehensive spectrum of psychomotor and cognitive dysfunctions, similar to many psychiatric disorders. Based on the observations from the current study, we proposed a role for HB-EGF in determining monoaminergic neural system and synaptic plasticity. Many psychiatric disorders are multifactorial, reflecting longitudinal and complex interactions of causative agents, including genetic and environmental factors. These findings indicate that the HB-EGF signaling may play a pivotal role in the pathogenesis of a number of psychiatric disorders, including schizophrenia.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Generation of HB-EGF KO mice using a gene targeting Cre-loxP and PCR
###end title 48
###begin p 49
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Iwamoto1">[21]</xref>
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007461-g001">Fig. 1a</xref>
###xml 1372 1376 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Furuta1">[22]</xref>
###xml 1681 1685 1681 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Iwamoto1">[21]</xref>
###xml 303 308 <span type="species:ncbi:10090">Mouse</span>
###xml 1094 1098 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1244 1248 <span type="species:ncbi:10090">mice</span>
###xml 1274 1278 <span type="species:ncbi:10090">mice</span>
###xml 1345 1360 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1410 1414 <span type="species:ncbi:10090">mice</span>
###xml 1451 1455 <span type="species:ncbi:10090">mice</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
###xml 1523 1527 <span type="species:ncbi:10090">mice</span>
###xml 1539 1543 <span type="species:ncbi:10090">mice</span>
###xml 1562 1566 <span type="species:ncbi:10090">mice</span>
###xml 1583 1587 <span type="species:ncbi:10090">mice</span>
###xml 1611 1616 <span type="species:ncbi:10090">mouse</span>
###xml 2020 2024 <span type="species:ncbi:10090">mice</span>
###xml 2049 2064 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2112 2116 <span type="species:ncbi:10090">mice</span>
###xml 2161 2165 <span type="species:ncbi:10090">mice</span>
###xml 2208 2212 <span type="species:ncbi:10090">mice</span>
The targeting strategy has been described previously [21]. The targeting construct is depicted in Fig. 1a. A 7.0-kb EcoRI-SacII fragment containing exon 1 of the HB-EGF gene, a 1.3-kb EcoRI-HindIII fragment from intron 3, and a 6.0-kb EcoRV fragment downstream of the exon 4 were used as homology arms. Mouse HB-EGF cDNA and a poly (A) signal flanked by loxP were fused at exon 1. A 4.0-kb HindIII-XhoI fragment containing the loxP-lacZ gene-poly (A) signal was inserted downstream of the HB-EGF cDNA. A neo cassette driven by the phosphoglycerate kinase promoter was inserted between the 1.3-kb intron 3 EcoRI-HindIII fragment and the 6.0-kb EcoRV fragment downstream of exon 4. XhoI-linearized DNA of the targeting vector was electroporated into TT2 embryonic stem (ES) cells. Individual clones were screened for homologous recombination by Southern blot analysis of HindIII-digested DNA, corresponding to sequences that flank the targeting vector 5'- and 3'-arm used in the screening of the HBlox allele. The targeted ES clones were injected into ICR blastocysts, and the resulting chimeric mice were bred with C57BL/6J female mice to obtain HB (lox/wt) mice. Homozygous HB (lox/lox) mice were then obtained by interbreeding the HB (lox/wt) mice. Homozygous HB (lox/lox) mice (C57BL/6J) were bred with Six3 promoter driven by Cre-recombinase transgenic mice (C57BL/6-) [22] to generate Six3-Cre-HB (lox/wt) mice. Subsequently, Six3-Cre-HB (lox/wt) mice were bred with HB (lox/lox) mice to generate Six3-Cre-HB (lox/lox) mice (HB-EGF KO mice) and HB (lox/lox) mice (HB-EGF control mice). The genotype of each mouse was confirmed by PCR. The primers have been reported previously [21]. Amplification was performed using a DNA thermal cycler (PERKIN ELMER, Norwalk, CT, USA) for 35 cycles. A cycle profile consisted of 30 sec at 94degreesC for denaturation and 30 sec at 53degreesC for annealing and primer extension. In the present study, to minimize the influence of different genetic backgrounds between HB (lox/lox) mice (C57BL/6J) and Six3-Cre transgenic mice (C57BL/6-), the generated Six3-Cre-HB (lox/wt) mice were backcrossed onto C57BL/6J HB (lox/lox) mice for more than 8 generations. HB (lox/lox) mice (C57BL/6J) used for backcrossing were maintained by inbred mating.
###end p 49
###begin title 50
Histological analysis
###end title 50
###begin p 51
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
Mice (male, 10-20 weeks old) were anesthetized with sodium pentobarbital (nembutal, 50 mg/kg, i.p., Dainippon Pharmaceutical, Osaka, Japan), and the brains were perfusion-fixed with 4% paraformaldehyde (Wako Pure Chemical Industries, Osaka, Japan) in 0.1 M phosphate-buffered saline (PBS) (pH 7.4). The brains were removed from the mice after 20 min of perfusion fixation at 4degreesC and then immersed in the same fixative solution. Brain sections were equilibrated in 25% sucrose solution and quickly frozen in Tissue-Tek O.C.T. (Sakura Finetek, Torrance, CA, USA).
###end p 51
###begin p 52
###xml 903 909 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hb-egf</italic>
###xml 1041 1045 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Kiuchi1">[52]</xref>
###xml 463 467 <span type="species:ncbi:9925">goat</span>
###xml 507 510 <span type="species:ncbi:10116">rat</span>
###xml 717 721 <span type="species:ncbi:9925">goat</span>
###xml 727 730 <span type="species:ncbi:10116">rat</span>
For lacZ staining, after fixation with 0.2% glutaraldehyde and 1% formalin, tissues were incubated with 5-bromo-4-chloro-3-indoly-beta-galactoside (X-Gal) (Active Motif, Carlsbad, CA, USA) for 2 hr at 4degreesC. For immunohistochemical staining, frozen sections were washed for 5 min in 0.01 M PBS and then treated with 0.3% hydrogen peroxidase in 10% methanol. They were then washed three times in 0.01 M PBS, followed by a 30 min pre-incubation with 10% normal goat serum. They were then incubated with a rat anti-HB-EGF antibody (1:200), including 0.3% triton X-100, overnight at 4degreesC. After a 15 min rinse in changes of 0.01 M PBS, the sections were incubated with a secondary antibody, Alexa 488-conjugated goat anti-rat IgG (Molecular Probes, Carlsbad, CA, USA). In situ hybridization analysis was performed using an antisense DIG-labeled cRNA probe. DIG-labeled cRNA probes corresponding to Hb-egf (NM_010415) nucleotide positions 546 to 665 were synthesized, in situ hybridization analysis was performed, as previously reported [52], and frozen sections (10 microm thick) were stained with cresyl violet (Sigma, St. Louis, MO, USA).
###end p 52
###begin title 53
Behavioral tests
###end title 53
###begin p 54
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice (male, 10-15 weeks old) were housed in a room with a 12-hr light/dark cycle (light on at 8:00 a.m.) and had ad libitum access to food and water. Behavioral tests were performed between 9:00 a.m. and 5:00 p.m., except for the 24-hr locomotor activity test. All procedures relating to animal care and treatment conformed to the Animal Care Guidelines of the Animal Experiment Committee of Gifu Pharmaceutical University.
###end p 54
###begin title 55
Locomotor activity test
###end title 55
###begin p 56
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
To measure the locomotor activity, a mouse was placed in the cage, [plastic cage (175x245x125 mm), wood-chips, food, and water]. Locomotion was measured every 1 hr for 1 day using digital counter with infrared sensor (NS-ASS01; Neuroscience, Inc, Tokyo, Japan). Animals were placed into the cages at 2:00 P.M. for a 24 period. The room light was on from 8:00 A.M. to 8:00 P.M. Vehicle (0.3% tartaric acid), clozapine (1.0 mg/kg, i.p.), or haloperidol (0.1 mg/kg, i.p.) was administrated once a day for 9 days, and one day after the final injection, locomotor activity test was started.
###end p 56
###begin title 57
Prepulse inhibition (PPI) test
###end title 57
###begin p 58
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Sakaue1">[53]</xref>
###xml 1376 1380 <span type="species:ncbi:10090">Mice</span>
Acoustic startle responses were measured in a startle chamber (SR-LAB; San Diego Instruments, San Diego, CA) using standard methods described previously [53]. In the demonstration of PPI of acoustic startle reflex, subjects were presented with a series of discrete trials comprising a mixture of four types of trials. These included pulse-alone trials, prepulse-plus-pulse trials, prepulse-alone trials, and trials in which no discrete stimulus, other than the constant background noise, was presented. A reduction of startle magnitude in prepulse-pulse-pulse trials relative to those in pulse-alone trials constitutes PPI. The pulse stimulus employed was 120 dB in intensity and 40 msec in duration. Prepulse of various intensities as employed: 73, 76, and 82 dB. The duration of prepulse stimuli was 20 msec. The stimulus onset asynchrony of the prepulse and pulse stimuli on prepulse-plus-pulse trial was 100 msec. A session began with the animals being placed into the Plexiglas enclosure. Clozapine (WAKO) was dissolved in 0.1N HCl in saline and neutralized to pH 6-7 with 0.1N NaOH. Haloperidol (WAKO) and risperidone (WAKO) were dissolved in distilled water containing 0.3% tartaric acid. Vehicle (0.3% tartaric acid), clozapine (1.0 mg/kg, i.p.) haloperidol (0.1 mg/kg, i.p.), and risperidone (0.1 mg/kg, i.p.) were administrated 30 min before the measurement of PPI. Mice were acclimatized to the apparatus for 5 min before the first trial began. Subsequently the animals were presented with 3 blocks of discrete test trials. Each block consisted of one trial of each of the following trial types: pulse-alone, prepulse-plus-pulse trials of each of the five levels of prepulse, prepulse-alone of each of the five levels of prepulse, and no stimulus (ie background alone). The interval between successive trials was variable with a mean of 30 sec (ranging from 20 to 40 sec).
###end p 58
###begin title 59
Social interaction test
###end title 59
###begin p 60
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-File1">[54]</xref>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
The social interaction test in a novel environment was done in a manner similar to published method [54]. Each mouse was housed in a group of 5-6 animals of the same genotype per cage during the test. Two mice of identical genotypes, which were previously housed in different cages, were placed into a box together (175x245x125 mm) and allowed to explore freely for 10 min. Social behavior was monitored by a video camera. The number and mean duration of contacts for 10 min after the start were measured. During the 10 min observation period, observers monitored the following behaviors: social interaction, sniffing, following, genital investigation, facing, and mounting. The score was calculated as the mean duration per contact. Haloperidol (0.1 mg/kg, i.p.) and clozapine (1.0 mg/kg, i.p.) were administrated once a day for 7 days, and one day after the final injection, social interaction test was started.
###end p 60
###begin title 61
Novel object recognition task
###end title 61
###begin p 62
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
Mice were tested in a circular arena, 40 cm in diameter. All mice were habituated in the apparatus (without objects) for 40 min per day prior to the training session. At the end of each trial, the animals were removed from the arena and the arena was cleaned with 70% ethanol solution and dried with paper toweling. Object recognition was scored by the amount of time spent for each object, with the nose of the mouse directed to and located within 2 cm from the object or with the anterior limbs touching the object. In a first trial (T1: 5 min) two similar objects (left and right: circle) were placed in a symmetrical position 5 cm away from the wall. In a second trial (T2: 5 min), two plastic dissimilar objects [one with a circle (left) and a new one triangle (right)] were presented. The number of account exploring each object during T1 and T2 was recorded. All mice were tested 1 hr between T1 and T2.
###end p 62
###begin title 63
Y-maze task
###end title 63
###begin p 64
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
Recording the spontaneous alteration behavior in Y-maze was assessed as spatial reference memory task. The apparatus consisted of three identical arms (50 lx16 wx32 h cm) made by black Plexiglas. Each mouse was placed at the end of one fixed arm and allowed to move freely through the maze during an 8 min session. The sequence of arm entries was recorded manually. An alternation was defined as entries into all three arms on consecutive choices. The number of maximum alternations was then the total number of arms entered minus two, and the percentage of alternation was calculated as (actual alternations/maximum alternations) x100. In addition, the total number of arms entered during the session was also determined.
###end p 64
###begin title 65
Measurements of monoamine neurotransmitters and metabolites
###end title 65
###begin p 66
###xml 5 10 <span type="species:ncbi:10090">mouse</span>
Each mouse (male, 10-20 weeks old) was decapitated under deep anesthesia and its brain quickly removed from the skull, briefly washed in ice-cold saline, and laid on a cooled (4degreesC) metal plate, on which it was rapidly dissected to separate the prefrontal cortex, striatum, cerebellum, and thalamus. The dissected brain regions were weighed, frozen, and stored at -80degreesC until analysis. The regional levels of monoamines and their metabolites were determined using a high-performance liquid chromatography (HPLC) system equipped with an electrochemical detector (HPLC-ECD System; Eicom, Kyoto, Japan). The HPLC system and conditions were as follows: Eicom EP-300/Eicom ECD-300 system; column, Eicompak SC-5ODS (3.0 mm i.d.x15 cm) with precolumn; mobile phase, 83% 0.1 M citric acid/0.1 M sodium acetate buffer, 17% methanol, 0.18% sodium 1-octanesulfonate, containing 5 mg/ml disodium-EDTA; flow rate, 0.5 ml/min; electrode, Eicom WE-3G graphite electrode; reference electrode, Eicom RE-100 Ag/Ag Cl; applied voltage, 750 mV versus Ag/Ag Cl. Column temperature was maintained at 25degreesC.
###end p 66
###begin title 67
Morphological analysis
###end title 67
###begin p 68
###xml 2181 2185 2157 2161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Peters1">[55]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 1142 1148 <span type="species:ncbi:9986">rabbit</span>
###xml 1327 1333 <span type="species:ncbi:9986">rabbit</span>
###xml 2518 2522 <span type="species:ncbi:10090">mice</span>
Mice were anesthetized with pentobarbital and perfused via the ascending aorta with phosphate-buffered saline (PBS; pH 7.4) until the outflow became clear, followed by 0.1 M phosphate buffer (PB; pH 7.4) containing 4% paraformaldehyde (PFA) for 15 min. Brains were removed and postfixed in the same fixative for 24 h at 4degreesC. The brain was sliced at 150 microm thickness using a vibratome (Dosaka EM Co. Ltd, Kyoto, Japan). The slices were transferred into a Silgard-coated Petri dish filled with 4', 6-diamidino-2-phenylindole (DAPI) solution (1 microg/ml; Sigma, St. Louis, MO) in PBS. Neurons in the infralimbic (IL) and prelimbic (PL) regions of the medial prefrontal cortex (mPFC) were penetrated with glass microelectrodes filled with 3% LY (lithium salt; Sigma) in distilled water, and LY was injected by passing 2-20 nA current with 2.5 second pulses applied at 0.2 Hz for 1-2 minutes. After LY injections, sections were postfixed in the same fixative for 1-2 days, and then were incubated as follows: several washes in PBS, 1 h in 0.1 M PBS containing with 1% BSA, 0.3% TritonX-100 and 0.1% NaN3 (blocking solution); and with a rabbit anti-LY polyclonal antibody (1:5000, Molecular probes) in blocking solution at 4degreesC for 4-5 days. After washing, sections were incubated for 3 h with Alexa 488-labeled anti-rabbit IgG (1:500, Molecular probes). After several washes in PBS, sections were mounted on slides with Vectashield (Vector Laboratory). Immunofluorescent images were analyzed using a confocal laser scanning microscope (Leica TCS). Pyramidal neurons within the infralimbic and prelimbic regions were defined by the presence of a single apical dendrite. For analyses of branching, basal dendrites were evaluated by counting the number of branches on each dendrite. Data were expressed as the mean number of branches per dendrite. The average spine density (number of spines per 10 microm of dendritic length) was estimated on the first segments of apical dendrites. For analyses of spine density and spine length, spines were identified on the basis of the morphological criteria for 'mushroom' and 'thin' spines described by Peters and Kaiserman-Abramof [55], with the only protrusions counted being those perpendicular to the dendritic shaft and possessing a clear neck and bulbous head. Spine length represents the radial distance from the tip of the spine head to the dendritic shaft. These morphological analyses were performed using 6 to 8 neurons each from five controls and HB-EGF KO mice.
###end p 68
###begin title 69
Immunoblotting analysis
###end title 69
###begin p 70
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007461-Towbin1">[56]</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 1294 1305 <span type="species:ncbi:3704">horseradish</span>
###xml 1333 1338 <span type="species:ncbi:10090">mouse</span>
###xml 1347 1353 <span type="species:ncbi:9986">rabbit</span>
Immunoblotting analyses of the prefrontal cortex region were performed using male, 10-week-old animals (controls and KO mice). Extracts prepared from the medial prefrontal cortex region were treated with Laemmli's sample solution and boiled for 3 min. Samples containing equivalent amounts of protein were separated on 10% sodium dodecyl sulfatepolyacrylamide gels and transferred for 2 hr at 70 V to a polyvinylidene difluoride membrane using the method of Towbin et al [56]. Membranes were then incubated for 1 hr in blocking solution containing 4% dry milk in T-TBS (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1% Tween 20) at room temperature and then incubated overnight at 4degreesC with antibodies against PSD-95 (1:250, Transduction Laboratories, Lexington, KY, USA), NR1, NR2A (1:1000, Upstate Biotechnology, Lake Placid, NY, USA), Nr2B (R&D Systems, Minneapolis, MN, USA), EGF receptor, ErbB4 (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), phospho-CaMKII (p-Thr286/p-Thr287) (1:5000), anti-CaMKII (1:5000),beta-tubulin (1:5000) ERK, p-ERK, AKT, p-AKT, PLCgamma, p-PLCgamma, phospho-PAK1 (Thr423), phospho-PAK2 (Thr402), or phospho-PAK3 (Thr421) (1:1000, Cell Signaling Technology, Beverly, MA, USA) in blocking solution. After washing in T-TBS, membranes were incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG to visualize primary antibodies using enhanced chemiluminescence plus western blotting detection reagent (Amersham Pharmacia Biotech, Amersham, UK), according to the manufacturer's protocol. The images were scanned and analyzed semi-quantitatively using NIH Image (Research Services Branch of the National Institute of Mental Health). Optical densities of corresponding immunoreactive bands were obtained by subtraction of the background density within the same image.
###end p 70
###begin title 71
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Autophosphorylation of ErbB receptor in HB-EGF KO mice
###end title 71
###begin p 72
Immunoblotting analyses of the autophosphorylation of the ErbB receptor were performed using the prefrontal cortex region. In this study, membrane protein was extracted using a Native Membrane Protein Extraction Kit (Calbiochem, Cambridge, MA, USA) according to the manufacturer's instructions. Then, membrane protein was immunoblotted using an anti-phospho-EGF receptor antibody and an anti-phospho-ErbB4 antibody (1:1000, Cell Signaling Technology), as described above.
###end p 72
###begin title 73
Statistical analysis
###end title 73
###begin p 74
###xml 169 170 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All data were expressed as the mean+/-SEM. Statistical significant was evaluated either by either one-way or two-way ANOVA test followed by a post hoc Dunnett's test. A P-value of <0.05 was considered to be statistically significant.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
Supporting figures
###end p 76
###begin p 77
(0.16 MB DOC)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Supporting Table
###end p 79
###begin p 80
(0.04 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
Supporting Table
###end p 82
###begin p 83
(0.02 MB DOC)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.
###end article-title 86
###begin article-title 87
###xml 12 17 <span type="species:ncbi:9606">human</span>
Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.
###end article-title 87
###begin article-title 88
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology.
###end article-title 88
###begin article-title 89
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.
###end article-title 89
###begin article-title 90
Heparin-binding EGF-like growth factor.
###end article-title 90
###begin article-title 91
N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
###end article-title 91
###begin article-title 92
Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: comparison with basic fibroblast growth factor.
###end article-title 92
###begin article-title 93
###xml 146 150 <span type="species:ncbi:10116">rats</span>
Epidermal growth factor and basic fibroblast growth factor promote the generation of long-term potentiation in the dentate gyrus of anaesthetized rats.
###end article-title 93
###begin article-title 94
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor.
###end article-title 94
###begin article-title 95
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain.
###end article-title 95
###begin article-title 96
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Expression of heparin-binding epidermal growth factor-like growth factor in rat brain.
###end article-title 96
###begin article-title 97
###xml 130 133 <span type="species:ncbi:10116">rat</span>
Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat.
###end article-title 97
###begin article-title 98
Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system.
###end article-title 98
###begin article-title 99
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons.
###end article-title 99
###begin article-title 100
Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.
###end article-title 100
###begin article-title 101
The neurodevelopmental model of schizophrenia.
###end article-title 101
###begin article-title 102
Neurodevelopmental aspects of bipolar affective disorder: Biol Psychiatry.
###end article-title 102
###begin article-title 103
Neurodevelopmental processes in the ontogenesis and epigenesis of psychopathology: Dev Psychopathol.
###end article-title 103
###begin article-title 104
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients.
###end article-title 104
###begin article-title 105
###xml 108 116 <span type="species:ncbi:9606">patients</span>
Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.
###end article-title 105
###begin article-title 106
Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.
###end article-title 106
###begin article-title 107
###xml 67 82 <span type="species:ncbi:10090">transgenic mice</span>
Retina- and ventral forebrain-specific Cre recombinase activity in transgenic mice.
###end article-title 107
###begin article-title 108
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP).
###end article-title 108
###begin article-title 109
###xml 8 14 <span type="species:ncbi:10090">murine</span>
Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development.
###end article-title 109
###begin article-title 110
Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.
###end article-title 110
###begin article-title 111
Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.
###end article-title 111
###begin article-title 112
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
###end article-title 112
###begin article-title 113
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
###end article-title 113
###begin article-title 114
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice.
###end article-title 114
###begin article-title 115
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
###end article-title 115
###begin article-title 116
A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
###end article-title 116
###begin article-title 117
Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines.
###end article-title 117
###begin article-title 118
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Genetic enhancement of learning and memory in mice.
###end article-title 118
###begin article-title 119
###xml 96 101 <span type="species:ncbi:10090">Mouse</span>
Effect of Chlorpromazine or Haloperidol on Formation of 3methoxytyramine and Normetanephrine in Mouse Brain.
###end article-title 119
###begin article-title 120
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.
###end article-title 120
###begin article-title 121
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
###end article-title 121
###begin article-title 122
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit.
###end article-title 122
###begin article-title 123
Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
###end article-title 123
###begin article-title 124
Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function.
###end article-title 124
###begin article-title 125
Morphological changes in dendritic spines associated with long-term synaptic plasticity.
###end article-title 125
###begin article-title 126
Activity-regulated dynamic behavior of early dendritic protrusions: evidence for different types of dendritic filopodia.
###end article-title 126
###begin article-title 127
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.
###end article-title 127
###begin article-title 128
###xml 116 131 <span type="species:ncbi:10090">transgenic mice</span>
Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.
###end article-title 128
###begin article-title 129
Regulation of spine morphology and spine density by NMDA receptor signaling in vivo.
###end article-title 129
###begin article-title 130
PSD-95 is required for activity-driven synapse stabilization.
###end article-title 130
###begin article-title 131
Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development.
###end article-title 131
###begin article-title 132
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization.
###end article-title 132
###begin article-title 133
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
The ontogeny of epidermal growth factor receptors during mouse development.
###end article-title 133
###begin article-title 134
HB-EGF promotes epithelial cell migration in eyelid development.
###end article-title 134
###begin article-title 135
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory.
###end article-title 135
###begin article-title 136
Clozapine-Induced ERK1 and ERK2 Signaling in Prefrontal Cortex Is Mediated by the EGF Receptor.
###end article-title 136
###begin article-title 137
###xml 21 26 <span type="species:ncbi:9823">swine</span>
Genomic structure of swine taste receptor family 1 member 3, TAS1R3, and its expression in tissues.
###end article-title 137
###begin article-title 138
###xml 106 110 <span type="species:ncbi:10090">mice</span>
The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
###end article-title 138
###begin article-title 139
Piracetam-a non-sedative anxiolytic drug? [proceedings].
###end article-title 139
###begin article-title 140
###xml 34 37 <span type="species:ncbi:10116">rat</span>
The small pyramidal neuron of the rat cerebral cortex. The perikaryon, dendrites and spines.
###end article-title 140
###begin article-title 141
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
###end article-title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: K. Yamaguchi is an employee of Nihon Bioresearch Center Inc. The other authors declare no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Funding was provided by the Gifu pharmaceutical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 143

